Author:
Mehmood Muzna,Ali Muhammad,Saleem Muhammad Amer,Asghar Sikandar,Hussain Muhammad Tanveer,Mehmood Asim
Abstract
The effect of intradermal TA on melasma was evaluated as a possible treatment modality on all of the 11 patients (fitting the inclusion criteria) presenting in the out-patient department of the Benazir Bhutto Hospital, Rawalpindi during Sep 2019 to Mar 2020. Their pre- and post-interventional results were evaluated after being injected with 4 mg/ml of TA on the lesions once weekly for 6 weeks, using Wilcoxon signed rank test in SPSS v 24.
The average duration of melasma in our patients was 25.3 ± 7.6 in months. The mean modified MASI score rating was 12.2 (2.3) and 5.1 (1.4) before and after intervention with intradermal TA respectively. The largest difference obtained in the mMASI scores of the patients was 10.8.
TA has a distinctive effect as a treatment modality for melasma, as it is easily employable with very few side effects.
Keywords: Melasma, Tranexamic acid, TA, intradermal TA, mMASI.
Publisher
Pakistan Medical Association
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献